# Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer

> **NCT00259285** · PHASE2 · TERMINATED · sponsor: **Eli Lilly and Company** · enrollment: 10 (actual)

## Conditions studied

- Non-Small-Cell Lung Cancer

## Interventions

- **DRUG:** pemetrexed
- **DRUG:** cisplatin

## Key facts

- **NCT ID:** NCT00259285
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-11
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Trial was stopped early due to low enrollment.
- **Last updated:** 2009-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259285, "Pemetrexed and Cisplatin Treatment Before Surgery in Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00259285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*